NASDAQ · Analyst Forecast

Eton Pharmaceuticals, Inc. (ETON) Stock Forecast & Price Target

$63.65 NASDAQ: ETON Market Cap $1.84B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Eton Pharmaceuticals, Inc. (ETON), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Eton Pharmaceuticals, Inc., analysts forecast revenue rising from $79.27M in 2025 to $530.30M in 2030; the average estimate for 2030 earnings per share is $6.96; with published estimates ranging from $6.61 to $7.50; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$63.65
Consensus targetThe average of the price targets analysts have published.$72.00
Median targetThe middle target, less affected by a single outlier.$70.00
Highest targetThe most optimistic published target.$78.00
Lowest targetThe most pessimistic published target.$68.00
Difference from priceHow far the consensus target sits from today’s price.+13.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$78.47M$79.27M$80.06M2
2026$179.66M$179.90M$180.14M3
2027$277.12M$286.90M$296.68M3
2028$324.20M$356.33M$411.78M4
2029$436.82M$454.02M$481.38M2
2030$510.22M$530.30M$562.26M2

Earnings per share forecast

YearLowAverageHighAnalysts
2025$0.27$0.37$0.472
2026$1.54$2.01$2.483
2027$2.04$2.90$3.753
2028$3.54$4.01$4.624
2029$5.36$5.64$6.082
2030$6.61$6.96$7.502

Eton Pharmaceuticals, Inc. (ETON) forecast — frequently asked questions

What is the analyst price target for Eton Pharmaceuticals, Inc.?

Analysts covering Eton Pharmaceuticals, Inc. (ETON) have a consensus price target of $72.00, 13.1% above the current price of $63.65. Published targets range from $68.00 to $78.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Eton Pharmaceuticals, Inc.'s earnings?

The average analyst estimate for Eton Pharmaceuticals, Inc. (ETON) earnings per share in 2030 is 6.96, with individual estimates between 6.61 and 7.50.

How much revenue is Eton Pharmaceuticals, Inc. expected to make?

Analysts forecast Eton Pharmaceuticals, Inc. (ETON) revenue of $530.30M in 2030, based on 2 published estimates.

How many analysts cover ETON?

4 analysts contribute estimates for Eton Pharmaceuticals, Inc. (ETON). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks

TEVA forecastZTS forecastVTRS forecastELAN forecastRDY forecastALKS forecastAMRX forecastLNTH forecastSUPN forecastBHC forecastAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.